Prolife Chemopharma Private Limited - Company Profile

It is a chemicals and materials private limited company based in Ankleshwar, Gujarat, India, established in 2005.
2005 Ankleshwar, Gujarat, India Active
Last Updated:
Access Report
About Prolife Chemopharma Private Limited

Prolife Chemopharma Private Limited, a active private limited company, was established on 07 February 2005 in Ankleshwar, Gujarat, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24230GJ2005PTC045431. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.29 M.

Formerly known as Prolife Pharmachem Private Limited, Atri Chemopharma Private Limited. It upholds a compliant status. Employing 23 professional, Its leadership includes Kishorbhai Vanmalibhai Kheni (Director), Karan Manindersingh Jolly (Director), Anureet Kaur Jolly (Director). Past directors included Harshaben Mahesh Jakasaniya, Nitaben Valamjibhai Desai, Hitesh Kesharichand Shah. It holds ₹11.26 Cr open charges and ₹22.15 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 5730, Road No. 57 (South), Nr. Seven Water Tank, G.I.D.C., Ankleshwar, Gujarat, 393002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2005PTC045431

  • Registration Number

    045431

  • Incorporation Date

    07 February 2005

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.29 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.29 M
  • Company Age 21 Year, 29 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 11.26 Cr
  • Satisfied Charges ₹ 22.15 Cr
  • Revenue Growth **** -35.14%
  • Profit Growth **** -22.29%
  • Ebitda **** -63.25%
  • Net Worth 51.00%
  • Total Assets -12.48%
Company report

Prolife Chemopharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Prolife Chemopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Prolife Chemopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Kishorbhai Vanmalibhai Kheni Director 10 Mar 2007 Current
Karan Manindersingh Jolly Director 12 Feb 2019 Current
Anureet Kaur Jolly Director 15 May 2021 Current
Vivek Kheni Rakeshbhai Director 17 Oct 2016 Current
Chetan Kapasi Chandrakant Director 15 Apr 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Aug 2014 Past
Pramod Abcsdd Director 15 Apr 2017 Past
Pramod Abcsdd Director 15 Apr 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Additional Director 15 Apr 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Prolife Chemopharma.

Prolife Chemopharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.14% decrease. The company also saw a substantial fall in profitability, with a 22.29% decrease in profit. The company's net worth Soared by an impressive increase of 51%.

Prolife Chemopharma revenue growth over time
Prolife Chemopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -35.14%
*******
*******
*******
*******
Revenue from Operations
*******
 -36.41%
*******
*******
*******
*******
Total Assets
*******
 -12.48%
*******
*******
*******
*******
Profit or Loss
*******
 -22.29%
*******
*******
*******
*******
Net Worth
*******
 51.00%
*******
*******
*******
*******
EBITDA
*******
 -63.25%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Prolife Chemopharma?

Unlock access to Prolife Chemopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹112,600,000.00

Satisfied Charges

₹221,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 11.94 Cr
  • Axis Bank Limited : 9.86 Cr
  • Navsarjan Industrial Co-Op Bank Ltd : 0.25 Cr
  • Navsarjan Industrial Co-Op Bank Ltd. : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
26 Aug 2021 Others ₹6.80 M Satisfied
23 Jun 2021 Others ₹6.80 M Satisfied
25 Mar 2021 Others ₹4.95 Cr Satisfied
17 Dec 2020 Others ₹6.80 M Satisfied
17 Dec 2020 Others ₹4.95 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Prolife Chemopharma?

Prolife Chemopharma has a workforce of 23 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Prolife Chemopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prolife Chemopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Prolife Chemopharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Prolife Chemopharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Prolife Chemopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    Progress on A charge registered on 26 Aug 2021 via Charge ID 100471806 with Others was fully satisfied on 12 Feb 2025. was documented.

  • Charges

    A charge registered on 25 Mar 2021 via Charge ID 100449421 with Others was fully satisfied on 12 Feb 2025. was recorded as a recent event.

  • Charges

    A charge registered on 17 Dec 2020 via Charge ID 100446766 with Others was fully satisfied on 12 Feb 2025. was recorded as a recent event.

  • Charges

    The activity A charge registered on 17 Dec 2020 via Charge ID 100446768 with Others was fully satisfied on 12 Feb 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Prolife Chemopharma Private Limited?

The CIN of Prolife Chemopharma Private Limited is U24230GJ2005PTC045431.

Where is Prolife Chemopharma Private Limited headquartered?

Prolife Chemopharma Private Limited is headquartered at Plot No. 5730, Road No. 57 (South), Nr. Seven Water Tank, G.I.D.C., Ankleshwar, Gujarat, 393002.

When was Prolife Chemopharma Private Limited incorporated?

Prolife Chemopharma Private Limited was incorporated on 07 February 2005.

Who are the current directors of Prolife Chemopharma Private Limited?

The current directors of Prolife Chemopharma Private Limited are

What is the primary industry of Prolife Chemopharma Private Limited?

The primary industry of Prolife Chemopharma Private Limited is Manufacturing.

Is Prolife Chemopharma Private Limited a listed company?

Prolife Chemopharma Private Limited is unlisted.

What is the capital structure of Prolife Chemopharma Private Limited?

The authorized capital of Prolife Chemopharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.29 M.

What is the compliance status of Prolife Chemopharma Private Limited?

The compliance status of Prolife Chemopharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available